Stocks › CRL

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL·NYSE·United States United States·USD
$314.32
-13.61 (-4.15%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · NYSE
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
CRLS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair

Congressional Trades

Recent trades of CRL by members of U.S. Congress · 30 on record · 2 in the last 12 months
All congressional trades →
PoliticianStockTypeFiledTraded
Ro KhannaRo KhannaHouse · D · CA CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. · Common Stock Purchase
$1,001 - $15,000
Apr 7, 2026 Mar 30, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. · Common Stock Sale
$1,001 - $15,000
Mar 9, 2026 Feb 5, 2026 Filing ↗
Jefferson ShreveJefferson ShreveHouse · R · IN CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. · Stock Purchase
$15,001 - $50,000
Jun 22, 2025 May 8, 2025 Filing ↗
Jefferson ShreveJefferson ShreveHouse · R · IN CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. · Stock Sale
$15,001 - $50,000
Jun 22, 2025 May 12, 2025 Filing ↗
Robert P. Bresnahan, Jr.Robert P. Bresnahan, Jr.House · R · PA CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. · Stock Sale
$1,001 - $15,000
May 31, 2025 May 15, 2025 Filing ↗
Ro KhannaRo KhannaHouse · D · CA CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. · Common Stock Sale
$1,001 - $15,000
May 12, 2025 Apr 15, 2025 Filing ↗
Ro KhannaRo KhannaHouse · D · CA CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. · Common Stock Sale
$1,001 - $15,000
May 12, 2025 Apr 9, 2025 Filing ↗
Robert P. Bresnahan, Jr.Robert P. Bresnahan, Jr.House · R · PA CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. · Stock Purchase
$15,001 - $50,000
May 8, 2025 Apr 8, 2025 Filing ↗
Ro KhannaRo KhannaHouse · D · CA CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. · Common Stock Purchase
$1,001 - $15,000
Apr 10, 2025 Mar 6, 2025 Filing ↗
Ro KhannaRo KhannaHouse · D · CA CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. · Common Stock Purchase
$1,001 - $15,000
Apr 10, 2025 Mar 12, 2025 Filing ↗
Ro KhannaRo KhannaHouse · D · CA CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. · Common Stock Purchase
$1,001 - $15,000
Mar 6, 2025 Feb 25, 2025 Filing ↗
Ro KhannaRo KhannaHouse · D · CA CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CMN Purchase
$1,001 - $15,000
Mar 6, 2025 Feb 19, 2025 Filing ↗
Julie JohnsonJulie JohnsonHouse · D · TX CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. · Stock Purchase
$1,001 - $15,000
Feb 12, 2025 Jan 15, 2025 Filing ↗
Ro KhannaRo KhannaHouse · D · CA CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. · Common Stock Sale
$1,001 - $15,000
Feb 6, 2025 Jan 22, 2025 Filing ↗
Ro KhannaRo KhannaHouse · D · CA CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. · Common Stock Sale
$1,001 - $15,000
Feb 6, 2025 Jan 17, 2025 Filing ↗
Lois FrankelLois FrankelHouse · D · FL CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. · Stock Sale
$1,001 - $15,000
Oct 10, 2023 Sep 8, 2023 Filing ↗
Lois FrankelLois FrankelHouse · D · FL CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. · Stock Purchase
$1,001 - $15,000
May 19, 2023 Apr 25, 2023 Filing ↗
Zoe LofgrenZoe LofgrenHouse · D · CA CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. · Stock Sale
$1,001 - $15,000
Sep 13, 2022 Aug 25, 2022 Filing ↗
Zoe LofgrenZoe LofgrenHouse · D · CA CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. · Stock Purchase
$1,001 - $15,000
Oct 7, 2021 Sep 30, 2021 Filing ↗
Donna ShalalaDonna ShalalaHouse · D · FL CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. · Stock Sale
$1,001 - $15,000
Apr 27, 2020 Jun 24, 2019 Filing ↗
Susie LeeSusie LeeHouse · D · NV CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. · Stock Sale
$1,001 - $15,000
Dec 5, 2019 Oct 8, 2019 Filing ↗
Susie LeeSusie LeeHouse · D · NV CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. · Stock Sale
$1,001 - $15,000
Dec 5, 2019 Oct 7, 2019 Filing ↗
Susie LeeSusie LeeHouse · D · NV CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. · Stock Purchase
$1,001 - $15,000
Sep 30, 2019 Aug 29, 2019 Filing ↗
Lamar SmithLamar SmithHouse · R · TX CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. · Stock Sale
$1,001 - $15,000
Oct 9, 2018 Sep 26, 2018 Filing ↗
Thomas MacArthurThomas MacArthurHouse · R · NJ CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. · Stock Purchase
$1,001 - $15,000
Oct 6, 2018 Sep 13, 2018 Filing ↗

Whale Activity

Position changes in CRL reported for 2026-09-30 by 698 institutional filers
Increased: 154New: 135Held: 95Decreased: 236Closed: 52No prior filing: 26
  • Increased154
  • New135
  • Held95
  • Decreased236
  • Closed52
  • No prior filing26
FilerSharesValueChange
FMR LLC6.0M$1.76Bincreased
BlackRock, Inc.3.8M$1.11Bdecreased
VANGUARD CAPITAL MANAGEMENT LLC3.1M$922.7Mdecreased
PRICE T ROWE ASSOCIATES INC /MD/3.0M$887.4Mincreased
VANGUARD PORTFOLIO MANAGEMENT LLC2.2M$645.8Mdecreased
STATE STREET CORP1.9M$552.8Mincreased
Invesco Ltd.1.9M$546.5Mdecreased
HARRIS ASSOCIATES L P1.4M$416.1Mdecreased
GEODE CAPITAL MANAGEMENT, LLC1.3M$382.9Mdecreased
ARIEL INVESTMENTS, LLC1.2M$352.0Mdecreased
EARNEST PARTNERS LLC1.1M$320.7Mdecreased
MASSACHUSETTS FINANCIAL SERVICES CO /MA/1.0M$299.1Mincreased

Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.

Insider Trading

Net shares bought (+) or sold (−) on the open market by CRL insiders, by quarter · Form 4
-100.0K-50.0K050.0K100.0K2025 Q1: 3,1892025 Q12025 Q2: -7802025 Q22025 Q3: -1,6002025 Q32025 Q4: 02025 Q42026 Q1: 252026 Q12026 Q2: -75.0K2026 Q22026 Q3: -91.0K2026 Q32026 Q4: -27.2K2026 Q4

Recent Insider Transactions

9,056 transactions on record · newest first
All insider activity →
InsiderTypeSharesPriceValueDate
FOSTER JAMES CDirector · Director Sale −24.0K $350.00 $8.4M Oct 22, 2026 Form 4 ↗
Parisotto Shannon MCEVP, Disc & Safety Assessment Sale −2,156 $344.41 $743K Oct 21, 2026 Form 4 ↗
Parisotto Shannon MCEVP, Disc & Safety Assessment Sale −981 $308.44 $303K Oct 5, 2026 Form 4 ↗
Coleman GlennEVP & Chief Financial Officer Purchase +10 $297.43 $3K Sep 30, 2026 Form 4 ↗
FOSTER JAMES CDirector Sale −33.6K $300.00 $10.1M Aug 25, 2026 Form 4 ↗
FOSTER JAMES CDirector Option exercise +12.4K $208.44 $2.6M Aug 25, 2026 Form 4 ↗
FOSTER JAMES CDirector Option exercise +21.1K $194.12 $4.1M Aug 25, 2026 Form 4 ↗
Girshick BirgitChief Executive Officer · Director Gift −528 $0.00 $0 Aug 19, 2026 Form 4 ↗
Parisotto Shannon MCEVP, Disc & Safety Assessment Sale −2,039 $294.12 $600K Aug 19, 2026 Form 4 ↗
Parisotto Shannon MCEVP, Disc & Safety Assessment Option exercise +2,039 $194.12 $396K Aug 19, 2026 Form 4 ↗
Andrews Nancy CDirector Sale −573 $285.24 $163K Aug 18, 2026 Form 4 ↗
Andrews Nancy CDirector Option exercise +573 $164.30 $94K Aug 18, 2026 Form 4 ↗
Girshick BirgitChief Executive Officer · Director Sale −6,500 $279.90 $1.8M Aug 11, 2026 Form 4 ↗
Girshick BirgitChief Executive Officer · Director Option exercise +6,500 $179.66 $1.2M Aug 11, 2026 Form 4 ↗
Parisotto Shannon MCEVP, Disc & Safety Assessment Sale −3,714 $279.66 $1.0M Aug 11, 2026 Form 4 ↗
Parisotto Shannon MCEVP, Disc & Safety Assessment Option exercise +3,714 $179.66 $667K Aug 11, 2026 Form 4 ↗
LaPlume Joseph WEVP, Corp Strategy & Develop Gift −257 $0.00 $0 Aug 10, 2026 Form 4 ↗
FOSTER JAMES CDirector Sale −28.7K $275.00 $7.9M Aug 10, 2026 Form 4 ↗
FOSTER JAMES CDirector Option exercise +28.7K $179.66 $5.2M Aug 10, 2026 Form 4 ↗
Knell Michael GunnarSVP, Finance and CAO Sale −736 $258.53 $190K Aug 6, 2026 Form 4 ↗

Fund Holders

Mutual funds and ETFs holding CRL · SEC Form N-PORT
FundSharesValue% of fundAs of
Fidelity Contrafund1.8M$410.0M0.23%Jun 30, 2026
VANGUARD TOTAL STOCK MARKET INDEX FUND
VANGUARD INDEX FUNDS
1.5M$347.0M0.02%Jun 30, 2026
Oakmark Select Fund
HARRIS ASSOCIATES INVESTMENT TRUST
1.5M$339.7M4.08%Jun 30, 2026
Allspring Special Mid Cap Value Fund
ALLSPRING FUNDS TRUST
1.5M$329.6M2.45%Jun 30, 2026
VANGUARD 500 INDEX FUND
VANGUARD INDEX FUNDS
1.2M$283.0M0.02%Jun 30, 2026
VANGUARD SMALL-CAP INDEX FUND
VANGUARD INDEX FUNDS
1.1M$250.6M0.13%Jun 30, 2026
Invesco S&P 500 Equal Weight ETF
Invesco Exchange-Traded Fund Trust
1.0M$232.8M0.24%Jul 31, 2026
Fidelity 500 Index Fund
Fidelity Concord Street Trust
625.3K$180.2M0.02%Aug 31, 2026
VANGUARD SMALL-CAP VALUE INDEX FUND
VANGUARD INDEX FUNDS
699.8K$158.7M0.23%Jun 30, 2026
iShares Core S&P 500 ETF
iShares Trust
662.6K$150.3M0.02%Jun 30, 2026

Mutual funds and ETFs whose N-PORT filings list CRL's shares (CUSIP 159864107), each fund at its latest report since Apr 21, 2026, largest positions first. Bonds, options and short positions are left out.

Activist & Passive Stakes

Schedule 13D / 13G beneficial-ownership filings
  • T. Rowe Price Associates, Inc.SCHEDULE 13G · passive (13G) · 3.0M shares6.3%
    Nov 16, 2026 · ↗
  • Invesco Ltd.SCHEDULE 13G/A · passive (13G) · 1.9M shares3.9%
    Nov 10, 2026 · ↗
  • Abigail P. JohnsonSCHEDULE 13G/A · passive (13G) · 5.9M shares12.4%
    Nov 5, 2026 · ↗
  • FMR LLCSCHEDULE 13G/A · passive (13G) · 5.9M shares12.4%
    Nov 5, 2026 · ↗
  • Abigail P. JohnsonSCHEDULE 13G/A · passive (13G) · 4.9M shares10.2%
    Sep 8, 2026 · ↗
  • FMR LLCSCHEDULE 13G/A · passive (13G) · 4.9M shares10.2%
    Sep 8, 2026 · ↗
  • Invesco Ltd.SCHEDULE 13G · passive (13G) · 3.0M shares6.2%
    Aug 13, 2026 · ↗
  • Abigail P. JohnsonSCHEDULE 13G/A · passive (13G) · 4.2M shares8.8%
    Aug 6, 2026 · ↗
  • FMR LLCSCHEDULE 13G/A · passive (13G) · 4.2M shares8.8%
    Aug 6, 2026 · ↗
  • Invesco Ltd.SCHEDULE 13G/A · passive (13G) · 2.4M shares4.9%
    May 6, 2026 · ↗

Corporate Lobbying

Estimated quarterly lobbying spending reported under the LDA, filings naming charles river laboratories international as client
$0$63K$125K$188K$250K2026 Q1: $70K2026 Q2: $70K2026 Q3: $80K2026
  • CAPITOL HILL CONSULTING GROUPCHARLES RIVER LABORATORIES INTERNATIONAL, INC · 2026 Q3 · HCR, FOO, PHA$80K
    Filing ↗
  • CAPITOL HILL CONSULTING GROUPCHARLES RIVER LABORATORIES INTERNATIONAL, INC · 2026 Q2 · HCR, FOO, PHA$70K
    Filing ↗
  • CAPITOL HILL CONSULTING GROUPCHARLES RIVER LABORATORIES INTERNATIONAL, INC · 2026 Q1 · HCR, FOO, PHA$70K
    Filing ↗
  • CAPITOL HILL CONSULTING GROUPCHARLES RIVER LABORATORIES INTERNATIONAL, INC · 2026 Q1 · HCR, FOO, PHA—
    Filing ↗
  • K&L GATES, LLPCHARLES RIVER LABORATORIES INTERNATIONAL, INC. · 2021 Q1—
    Filing ↗

Government Contracts

Federal awards to CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · USAspending

No federal contract awards found for CHARLES RIVER LABORATORIES INTERNATIONAL, INC..

U.S. Patents

Recent USPTO applications naming CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

No USPTO patent applications found for CHARLES RIVER LABORATORIES INTERNATIONAL, INC..

Annual Financials

From CRL's 10-K filings · XBRL
Fiscal yearFY2025FY2024FY2023FY2022FY2021
Revenue$4.02B$4.05B$4.13B$3.98B$3.54B
Operating income$25.2M$227.3M$617.3M$651.0M$589.9M
Net income-$144.3M$22.2M$474.6M$486.2M$391.0M
Diluted EPS-$2.91$0.20$9.22$9.48$7.60
Operating cash flow$737.6M$734.6M$683.9M$619.6M$760.8M
Cash and equivalents$213.8M$194.6M$276.8M$233.9M$241.2M
Total assets$7.14B$7.53B$8.20B$7.60B$7.02B
Total liabilities$3.92B$4.02B$4.54B$4.58B$4.43B
Shareholders' equity$3.16B$3.46B$3.60B$2.98B$2.53B

As CHARLES RIVER LABORATORIES INTERNATIONAL, INC. tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Feb 18, 2026 ↗

Stock Splits

Every split and reverse split in the price history

No stock splits in CRL's price history.

Material Events (8-K)

Corporate events filed with the SEC
  • 8-K · Items 7.01, 9.01Reg FD disclosureNov 9, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsNov 4, 2026
    EDGAR ↗
  • 8-K · Items 7.01, 9.01Reg FD disclosureSep 24, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsAug 5, 2026
    EDGAR ↗
  • 8-K · Items 5.02, 5.07, 9.01Officer / director change · Shareholder voteMay 11, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsMay 7, 2026
    EDGAR ↗

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

From SEC EDGAR company records
Industry (SIC 8731)Services-Commercial Physical & Biological Research
SectorIndustrials
HeadquartersWILMINGTON, MA
Former namesCHARLES RIVER LABORATORIES INTERNATIONAL INC, CHARLES RIVER LABORATORIES HOLDINGS INC